---
schema_version: "secwatch.filing_event.v1"
accession: "0001477932-24-002229"
form_type: "8-K"
ticker: "BGLC"
cik: "0001737523"
company_name: "BioNexus Gene Lab Corp"
filed_at: "2024-04-18T23:59:59+00:00"
generated_at: "2026-06-03T19:09:48.354688+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# BioNexus Gene Lab invests RM1.2M for 10% stake in Malaysian digital health firm AISB

## Summary
- Investment of RM1.2M (~$250k) via subsidiary MRNA Scientific for ~10% equity in Ascension Innovation (AISB).
- Funding to accelerate AISB's AI platform aiCMS with predictive analytics, AI diagnosis aids, and more.
- AISB projects revenue of RM75M collectively for 2024-2028; currently 145k+ users and 30+ providers.
- Investment supports BGLC's genomic diagnostics integration into AISB's platform to expand market reach.

## SEC filing metadata
- accession: 0001477932-24-002229
- form_type: 8-K
- ticker: BGLC
- cik: 0001737523
- company_name: BioNexus Gene Lab Corp
- filed_at: 2024-04-18T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 7.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1737523/000147793224002229/0001477932-24-002229-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1737523/000147793224002229/bglc_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001477932-24-002229
- JSON: https://secwatch.observer/filing/0001477932-24-002229.json
- Plain text: https://secwatch.observer/filing/0001477932-24-002229.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.